Monitoring renal safety in mineralocorticoid receptor antagonist trials

被引：1
|
作者：
Zannad, Faiez [1 ,2 ]
机构：
[1] Univ Lorraine, INSERM, Clin Invest Ctr 1433, Nancy, France
[2] CHRU, Nancy, France
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2017年 / 19卷 / 04期
关键词：
PRESERVED EJECTION FRACTION; SEVERE HEART-FAILURE; SPIRONOLACTONE; HYPERKALEMIA; SURVIVAL;
D O I：
10.1002/ejhf.764
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：466 / 468
页数：3
相关论文
共 50 条
  • [21] Adverse Effects of Mineralocorticoid Receptor Antagonist Administration
    Kallistratos, Manolis S.
    Pittaras, Andreas
    Theodoulidis, Iakovos
    Grassos, Charris
    Poulimenos, Leonidas E.
    Manolis, Athanasios J.
    CURRENT PHARMACEUTICAL DESIGN, 2018, 24 (46) : 5537 - 5541
  • [22] Mineralocorticoid receptor antagonist use in renal dialysis: will evidence from prospective randomized trials confirm the results from 'real-world' evidence?
    Rossignol, Patrick
    Pitt, Bertram
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 (03) : 361 - 363
  • [23] Mineralocorticoid Receptor Antagonists in End-Stage Renal Disease: Efficacy and Safety
    Bomback, Andrew S.
    BLOOD PURIFICATION, 2016, 41 (1-3) : 166 - 170
  • [24] Sulfenic Acid Modification of Endothelin B Receptor is Responsible for the Benefit of a Nonsteroidal Mineralocorticoid Receptor Antagonist in Renal Ischemia
    Barrera-Chimal, Jonatan
    Prince, Sonia
    Fadel, Fouad
    El Moghrabi, Soumaya
    Warnock, David G.
    Kolkhof, Peter
    Jaisser, Frederic
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2016, 27 (02): : 398 - 404
  • [25] Cardiac and renal protection by a new mineralocorticoid receptor antagonist in salt-sensitive arterial hypertension
    Kolkhof, P.
    Flamme, I.
    Figueroa Perez, S.
    Baerfacker, L.
    Hartmann, E.
    Rinke, M.
    Schaefer, S.
    EUROPEAN HEART JOURNAL, 2006, 27 : 110 - 110
  • [26] Consistency of Laboratory Monitoring During Initiation of Mineralocorticoid Receptor Antagonist Therapy in Patients With Heart Failure
    Cooper, Lauren B.
    Hammill, Bradley G.
    Peterson, Eric D.
    Pitt, Bertram
    Maciejewski, Matthew L.
    Curtis, Lesley H.
    Hernandez, Adrian F.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 314 (18): : 1973 - 1975
  • [27] MINERALOCORTICOID RECEPTOR ANTAGONIST HAS BENEFICIAL RENAL EFFECTS IN A NEW MOUSE MODEL OF DIABETIC NEPHROPATHY
    Posada, Ixchel Lima
    Ramirez, Roberto Palacios
    Bonnard, Benjamin
    Genty, Marie
    Jaisser, Frederic
    JOURNAL OF HYPERTENSION, 2021, 39 : E306 - E306
  • [28] The renal effects of mineralocorticoid receptor antagonists
    Bianchi, Stefano
    Batini, Valentina
    Bigazzi, Roberto
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 200 : 20 - 24
  • [29] Renal mineralocorticoid receptor and electrolyte homeostasis
    Terker, Andrew S.
    Ellison, David H.
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2015, 309 (09) : R1068 - R1070
  • [30] A selective antagonist of mineralocorticoid receptor eplerenone in cardiology practice
    Gegenava, B. B.
    Drapkina, O. M.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2015, 11 (02) : 177 - 181
12345